AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Symptomatic early neurosyphilis may be more common in HIV patients; CFTX may be therapy. (San Francisco) (ceftriaxone) (Informative Briefs From Worldwide Sources)
Officials of the U.S. Centers for Disease Control (CDC) reported on September 30, 1991, at the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) meeting in Chicago, Illinois, that symptomatic early neurosyphilis may be more common in the HIV infected patient.
In a report titled "Neurosyphilis in San Francisco during the AIDS Epidemic 1985-1989," J. M. Flood et al. said that while cases of infectious syphilis declined in San Francisco from 1,200 in 1982 to 378 in 1989, "early symptomatic neurosyphilis cases doubled over the study period."
"87 percent of early symptomatic neurosyphilis was found in HIV positive patients and those …
